Buy - Jai Balaji Industries for long term

Jai Balaji Industries
BSE : 532976
NSE: JAIBALAJI
CMP: 39.25

Buy Jai Balaji at CMP for a long term one year target of 84.00 with strict stop loss of 34.70

MEDIUM TERM BUY CALL - PUNEET RESINS

BSE Code: 526492

Last Close: Rs.37.25

     Investors can buy this stock with stop loss of Rs.33. On the upper side, the stock will zoom to Rs.48 to Rs.55 levels in the medium-term.

JAGSONPAL PHARMACEUTICALS LTD

Jagsonpal Pharmaceuticals Ltd.  BSE Code: 507789, Last Close: Rs.13.41.

     Investors can buy this stock with stop loss of Rs.12. On the upper side, the stock will zoom to Rs.14 level. A close above will take it to Rs.16.50 to Rs.18 levels in the short term.

STOCKS IN THE NEWS FOR THE WEEK APRIL 16 - 22.

* Ajanta Pharma has shot up siginificantly in the last two months. Time to book partial profit and play safe.

* Share price of Indraprastha Gas has crashed over 30% in single day as PNGRB directed to reduce its selling prices for certain types of gas in New Delhi. Hold on and don’t book losses in panic.

* Paper companies are witnessing some buying interest from certain group of investors. Hold on to JK Paper and TNPL

* At a market cap of Rs.80 crore, Revathi Equipment is worth a punt. In the long run it seems to be a good takeover candidate by some MNC.

* Small tractors are in great demand in foreign markets. M&M, Escorts look good.

* ALSTOM and BGR are in for good times with big orders flowing in from Jyoti Structures and Powergrid for the former and NTPC for the latter.

* MNC counters like Fairfield Atlas, Morganite Crucible, Foseco, BASF India and Federal-Mogul have attracted good investor enquiries and are expected to fetch decent gains on expectation of delisting offers going forward.

* Aries Agro is reportedly faring well with a likely EPS of over Rs.20 in FY12 and Rs.25 in FY13. The share is going cheap.

* A banking analyst strongly recommends United Bank of India with a likely appreciation of about 40%. Buy for decent gain.

* CG Igarashi Motors, which was recently taken over by HBL Power has major expansion plans. The share is poised to advance further.

* AGC Network formerly Avaya Global and taken over by Aegis Global of the Essar Group, is expected to post an EPS of Rs.40+ in FY12. The share is poised to touch Rs.300 shortly.

* One infra analyst strongly recommends the shares of KNR Constructions, MBL Infra and JMC Projects for 30% return in the medium term.

* Torrent Cables is likely to clock an EPS of Rs.20 in FY12. The share has all the potential to appreciate by over 33% in the medium term.

* An Ahmedabad based technical analyst recommends Alstom Projects, IVRCL, Ind-Swift, MT Educare, R.S. Software and Twilight Litaka Pharma to accumulate at every decline.

BEST B

CLARIS LIFESCIENCES - SHORT TERM TERGET REACHED

Claris lifesiences recommended at Rs.143 on 21-march '12 for short term target Rs. 175 reached today trading  at Rs. 174.75 hope you are enjoy.

TOWER TALK

* M&M is the best beneficiary in the auto segment post budget. Even the Disel price hike may not dampen its spirit!

* Bharti Airtel will score over Idea and Rcom as the interest of 'smart’ and 'rare' investors rests here.

* ITC has always had its best moves post budget and swallowed the excise rise smartly. This year, too, it has begun to scale a new high.

* LIC Housing Finance is all set to surpass Rs.400 mark says the market wizard.

* Tamil Nadu raises power tariff, so does poor and ‘aam aadmi's’ Mamata. Will Akhilesh Yadav follow suit?

* Braun, a German healthcare company, has acquired majority stake in Ahlcon Parenteral at a very rich valuation and has come out with open offer at Rs.460 per share. Hold on as at it may soon turn into a delisting story.

* Post the open offer by promoters at Rs.7 per share, the share price of Aksh Optifibre has tripled over the last few months. At market cap of Rs.200 crore, it is a pure sell.

* Provogue (India) is trading arguably cheap at a valuation of Rs.165 crore. Worth buying and holding for a year or so.

* IVRCL counter may see some action with the ongoing race for ownership between Subhach Chandra of Essel and Sudhir Reddy.

* The shares of ITD Cementation can be bought for decent gain as it is likely to post an EPS of Rs.18-20 in the current year. The share is poised to touch Rs.250 mark.

* KNR Constructions is expected to post an EPS of Rs.24 in FY12 and Rs.28-30 in FY13. The share is going cheap and may advance by over 50% in the medium-term.

* With a likely EPS of Rs.18 in FY12 and Rs.22-24 in FY13 post expansion, the share of Pitti Laminations is an excellent buy. The share is poised to touch Rs.100 in the medium-to-short-term.

* The IFB Agro counter is witnessing hectic investment buying on its strong fundamentals. The liquor major is likely to post an EPS of Rs.42-45 in FY12. A conservative P/E of even 8 will take the share price to over Rs.340 mark.

* Some IT analysts are extremely bullish on Zensar Technologies, which is expected to post an EPS of Rs.40 in FY12. A conservative P/E of even 6 will take its share price to Rs.240 in the medium-to-short-term 

* ASM Technologies, a small cap IT firm, is expected to clock an EPS of Rs.22 in FY12 and Rs.28 in FY13. The share is sure to touch Rs.100 mark.

REVIEW OF RECENT RECOMMENDATIONS

We recommend on 25th March Prakash Industries @Rs 45/- and Hyderabad industries @Rs 327/- now trading @ Rs.53.30/- (buyer's ceiling) and Rs 353.45/- Respectively. IVRCL recommends @ Rs.60.05/- on 29th March now trading @ Rs.71/-.   Power of MULTIBAGGER MANIA ......ENJOY

TARGET REACHED IN 2nd TRADING SESSION

NUTRAPLUS PRODUCT(INDIA)LTD RECOMMEND TO BUY FOR LONG TERM YESTERDAY. BUT THE TARGET 26 (30%).. (HIGH 26.60) REACHED IN SECOND TRADING SESSION. ENJOY.

Nutraplus Products (India) Ltd

BSE Code: 524764
Last Close: Rs.19.25
           NutraPlus India Ltd. (NPIL) is a limited company. It was incorporated as a private limited company in February 1990 and commenced the manufacture of APIs and Intermediates in 1995 for the domestic and overseas markets. Its product portfolio includes N Bromo Succinimide, a brominating compound; N Methyl Nitro Guanidine, an intermediate for insecticides; Chlorhexidine Gluconate, an anti infectant; 7-hloroQuinaldine, an intermediate of the Montelukast drug; and M Bromo Anisole, an intermediate of API Tramadol HCL.It has an equity base of Rs.5.20 crore that is supported by reserves of around Rs.4.64 crore. The promoters hold 48.31%, non-promoter corporate bodies hold 1.93%, foreign investors hold 4.85% while the investing public holds 44.84% stake in the company.The Q3FY12 EPS is Rs.2.10 while the nine monthly EPS is Rs.6.06. At the current level, the stock is available at a P/E multiple of just 2.3.
        Just look at its past performance. Every year, the stock has shown fantastic growth in sales and volume, which indicates that the company will do well in future. At the current level, the stock is available at a throwaway price as per the P/E ratio. We are, therefore, recommending to buy this stock for medium-to-long-term investment as the company may report an EPS of Rs.8+ for FY12 and may declare dividend this year. Investors can buy this stock with stop loss of Rs.17. On the upper side, the stock will zoom to Rs.26-30 levels in the medium-to-long-term.

NAVA BHARAT VENTURES LTD - BUY

Nava Bhart Ventures Ltd

BSE : 513023, NSE : NBVENTURES , CMP : 217.25. Buy at 217 - 220 levels for a short term one month target of 240 with sl 195.65. Also recommend to buy for long term with stop loss 199.50.